Your session is about to expire
← Back to Search
Brain Stimulation for Dementia (COBALT Trial)
COBALT Trial Summary
This trial is testing whether high-definition transcranial direct current stimulation (HD-tDCS) to the preSMA/dACC region can help improve episodic memory and word recall in patients with mild cognitive impairment (MCI) or dementia.
COBALT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowCOBALT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.COBALT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am taking medication that affects brain stimulation treatments.I have been diagnosed with mild cognitive impairment or dementia.I am either a man or a woman.I am 55 years old or older.People of all races and ethnicities are welcome to participate.I am either a man or a woman.
- Group 1: Phase 1: Sham Treatment
- Group 2: Phase 2: Active Treatment
- Group 3: Phase 1: Active Treatment
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What aims is this research project striving to accomplish?
"Investigating the primary outcome of this clinical trial, which will span pre-treatment to 8 weeks post-treatment, is Changes in Rey Auditory Verbal Learning Test Score. Secondary outcomes involve assessing Changes in Boston Naming Test Short Form (ranging from 0-30 with higher scores indicating better performance) and Delis Kaplan Executive Function System Verbal Fluency Test (0-no upper limit for each trial). For both of these measures changes are measured between baseline and immediately after condition completion as well as between baseline and 8 months post-treatment."
Is enrollment for this experiment currently underway?
"Clinicaltrials.gov indicates that this particular medical trial, initially posted on the 1st of November 2022 and last updated 18th October 2022, is no longer seeking participants. Nonetheless, 887 other clinical trials are currently taking candidates."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger